Gsk Q1 2024 Earnings. Zacks research also issued estimates for gsk’s q3 2024 earnings at $1.18 eps, fy2024 earnings at $4.12 eps and q1 2025 earnings at $1.08 eps. Gsk began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as.
Year ago +0.92 q1 2023: The latest price target for.
Gsk Has Been Growing Earnings At An Average Annual Rate Of 0.5%, While The Pharmaceuticals Industry Saw Earnings Growing At 1.6% Annually.
Year ago +0.92 q1 2023:
Total Eps 35.9P +67% Aer, +66% Cer And Adjusted Eps 32.8P +43% Aer, +43%.
The last reported earnings were for reported on january 31, 2024 for q4.
Year Ago +1.20 Fy 2023:
Images References :
Despite An Improvement In The Eps Estimates From Usd 3.9 The Last.
I'm very pleased to share our q1 2022 results, which demonstrate a strong start to this landmark year for gsk.
The Latest Price Target For.
Gsk has been growing earnings at an average annual rate of 0.5%, while the pharmaceuticals industry saw earnings growing at 1.6% annually.
In The Last Quarter Glaxosmithkline Reported $0.736 Eps In Relation To $0.736 Expected By The.